Structure‐Informed Design of Distinct Parallel G‐Quadruplex Stabilizers for KRAS ‐Driven Cancer Therapy
Angewandte Chemie International Edition · 03.08.2026 · 65 (32)
DOI: 10.1002/anie.8271527 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 07.06.2026. Verfasst von Lulu Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Basic Medical Research Innovation Center for Anti-Cancer Drugs (Ministry of Education of China), and Jiang…. Hauptthemen laut MEDLINE: G-Quadruplexes, Proto-Oncogene Proteins p21(ras), Antineoplastic Agents, Drug Design. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Innovation and Entrepreneurship (Shuangchuang) Program of Jiangsu Province (2024), Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Targeting oncogene promoter G‐quadruplexes (G4s) is a compelling therapeutic strategy against human malignancies. However, clinical progress has been hindered by the lack of potent and structurally diverse G4‐targeting ligands. Herein, using parallel KRAS proximal promoter G4 ( KRAS ‐G4) as a model system, we screened an in‐house natural product library and identified dehydroevodiamine (DEE) as a novel G4 stabilizer. Although DEE showed only modest anticancer activity, structural analyses determined its predominant binding mode to KRAS ‐G4. Leveraging these structural insights, we rationally designed and synthesized 15 DEE analogues. Among them, compound 7i emerged as the lead candidate, demonstrating a 9‐fold higher binding affinity and up to 20‐fold improvement in antiproliferative activity over DEE. We further determined the high‐resolution NMR structure of the KRAS ‐G4– 7i complex, uncovering a distinct dual‐binding mode, featuring extensive π–π stacking interactions with outer G‐tetrads and specific hydrogen bonding within groove regions. Functional analysis showed 7i effectively suppressed transcription of several G4‐containing oncogenes, induced genome‐wide G4 formation, and triggered DNA damage in colorectal cancer cells. Moreover, 7i significantly inhibited the growth of patient‐derived colorectal tumor organoids. Overall, our findings establish a structural framework for rational design of parallel G4‐targeting ligands and emphasize an alternative G4‐based therapeutic strategy for KRAS ‐driven cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, Basic Medical Research Innovation Center for Anti-Cancer Drugs (Ministry of Education of China), and Jiangsu Key Laboratory of Bioactive Natural Product Research, China Pharmac…
- Xiangtan Central Hospital/Affiliated Hospital of Hunan University, School of Biomedical Sciences, Hunan University, Changsha, People's Republic of China.
- Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, People's Republic of Ch…
- Department of General Surgery, The Second Xiang Ya Hospital of Central South University, Changsha, People's Republic of China.
ORCID-Profile: Jun Zhou, Shengen Yi, Shengtao Xu, Ling-Yi Kong, Kai-Bo Wang
Förderung
- National Natural Science Foundation of China
- Innovation and Entrepreneurship (Shuangchuang) Program of Jiangsu Province (2024)
- Fundamental Research Funds for the Central Universities
- Department of Science and Technology of Hunan Province
- State Key Laboratory of Natural Medicines
- Scientific Research Foundation for High-Level Faculty
Zitieren
APA
Zhang, L., Han, K., Wang, X., Yu, X., Zhang, Y., He, S., Han, Z., Liu, Y., Su, J. C., Zhou, J., Yi, S., Xu, S., Bian, J., Zheng, K., Kong, L. Y., & Wang, K. B. (2026). Structure‐Informed Design of Distinct Parallel G‐Quadruplex Stabilizers for KRAS ‐Driven Cancer Therapy. Angewandte Chemie International Edition, 65(32). https://doi.org/10.1002/anie.8271527
Vancouver
Zhang L, Han K, Wang X, Yu X, Zhang Y, He S, et al. Structure‐Informed Design of Distinct Parallel G‐Quadruplex Stabilizers for KRAS ‐Driven Cancer Therapy. Angewandte Chemie International Edition. 2026;65(32). doi:10.1002/anie.8271527
BibTeX
@article{Zhang2026,
author = {Zhang, Lulu and Han, Kang and Wang, Xiaozhe and Yu, Xiaolin and Zhang, Yongqiang and He, Sihan and Han, Zhiwei and Liu, Yushuang and Su, Jun-Cheng and Zhou, Jun and Yi, Shengen and Xu, Shengtao and Bian, Jinlei and Zheng, Kewei and Kong, Ling-Yi and Wang, Kai-Bo},
title = {Structure‐Informed Design of Distinct Parallel G‐Quadruplex Stabilizers for KRAS ‐Driven Cancer Therapy},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {32},
doi = {10.1002/anie.8271527}
}
EUVIMED